LivaNova (LIVN) FCF Payout Ratio Growth (1y) (2017)
LivaNova (LIVN) FCF Payout Ratio Growth (1y) (2017) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.91 Bn | 193.31 Bn | 7.27 Bn | -16.90% |
| 2 | Stryker | 127.59 Bn | 124.11 Bn | 4.50 Bn | -8.00% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 0.45% |
| 4 | Boston Scientific | 73.24 Bn | 72.70 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.38 Bn | 32.44 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.96 Bn | 31.85 Bn | 2.18 Bn | -88.24% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -11.29% |
| 9 | Steris | 23.08 Bn | 22.60 Bn | 684.20 Mn | 27.54% |
| 10 | LivaNova | 4.29 Bn | 3.77 Bn | 273.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | -89.30% |